Midi Health, the virtual care company best known for providing hormone therapy for women in menopause, is expanding to ...

Eisai and Merck succeeded in stopping Shilpa Medicare Ltd. from launching a generic version of Lenvima for at least another ...

As of Thursday morning, just over 300 entries out of at least 950 public comments have been released by the Department of ...

Taysha Gene Ther­a­pies re­veals plans for piv­otal tri­al, $200M of­fer­ing: The biotech on Wednes­day … Get free access to a limited number of articles, plus choose newsletters to get straight to ...

Intellia Therapeutics reports serious liver enzyme elevation in one patient during Phase 3 trial of nex-z gene editing ...

For Illumina, its former employees are both a boon and a problem. In the 27 years since its founding, the DNA sequencing ...

The companies said Thursday that they voluntarily withdrew the accelerated approval request for patritumab deruxtecan in ...

After a slight delay, the FDA rejected Stealth BioTherapeutics' Barth syndrome drug application for elamipretide, but will ...

EDO51 for Duchenne muscular dystrophy after Phase 2 trial failure, abandons three preclinical programs, and pivots to focus ...

Strand Therapeutics reports early positive data for STX-001, a self-replicating mRNA cancer therapy, showing safety and ...

The Trump administration has killed two awards worth $766 million to help Moderna develop a bird flu vaccine, according to the company.

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of ...